- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05563415
AWV Practice Redesign Toolkit (Tailored Intervention)
Medicare Annual Wellness Visit Practice Redesign Toolkit: A Tailored Intervention to Improve Preventive Health Services Use (Phase 2)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a multi-site, stepped wedge cluster randomized controlled trial to evaluate the effect of the AWV Practice Redesign Toolkit on AWV and preventive health services use. The study will take place in 16 primary care practices around the United States. Eight practices will participate in the main clinical trial, and 8 in a replication study. The main clinical trial (with community-based practices) and replication study (with Federally Qualified Health Center practices) will be conducted simultaneously. Recruitment occurs at the level of the practice. The investigators hypothesize that the intervention will increase uptake of AWVs and use of preventive health services.
The stepped wedge cluster design is a pragmatic study design that includes an initial control period in which no clusters receive the intervention. Randomized clusters cross to the intervention condition at regular intervals, and there is a period at the end of the study where all clusters have been exposed to the intervention. Data are collected throughout the study so that each cluster contributes to both the control and intervention periods. The intervention will be implemented sequentially over 16 months, with 4 clusters of 4 practices each switching from control to intervention every 4 months between months 4-20. By month 20 of the study all practices will have completed intervention implementation. Each cluster will have a 4 month transition period during intervention implementation.
In addition to the procedures described above, the investigators will collect qualitative semi-structured interview data on a subset of patients (up to n=10), and clinicians/staff (up to n=10) from each practice to assess fidelity to the intervention.
Outcomes will be assessed through EHR data extractions, which will be led by the DARTNet Institute (co-investigator Wilson Pace). Data will be sent from the DARTNet Institute to the American Academy of Family Physicians National Research Network (AAFP NRN) for cleaning, de-identification and creation of flags. The AAFP NRN has established contracts and agreements with the DARTNet Institute that enables them to access DARTNet's data. The AAFP NRN will deliver a limited dataset to investigators at the University of California, Los Angeles for analyses.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90024
- University of California, Los Angeles
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
There are no inclusion or exclusion criteria based on sex/gender, race, and/or ethnicity.
Inclusion Criteria:
- have Medicare coverage
- aged 50 or older
- has at least one visit to the practice in the past 12 months
- not deceased
Practice eligibility criteria:
- care for patients with Medicare insurance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Medicare AWV Toolkit
This is a stepped-wedged study.
All practices will receive the intervention.
|
Electronic health record-based tools coupled with practice redesign strategies and approaches
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AWV utilization
Time Frame: through study completion, 12 months after intervention implementation in all practices
|
% of eligible patients completing an AWV (CPT codes G0438 or G0439) or Initial Preventive Physical Examination (IPPE) (CPT code G0422) in the past 12 months
|
through study completion, 12 months after intervention implementation in all practices
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Completion of recommended preventive health services
Time Frame: through study completion, 12 months after intervention implementation in all practices
|
% of patients up to date on each of the preventive health services listed below. Vaccinations
Cancer screening
Other screening
|
through study completion, 12 months after intervention implementation in all practices
|
Completion of recommended preventive health services - composite score
Time Frame: through study completion, 12 months after intervention implementation in all practices
|
% of total recommended preventive health services that are up to date (of a maximum of 12 recommended services per patient); measured on the patient-level
|
through study completion, 12 months after intervention implementation in all practices
|
Overuse of preventive health services
Time Frame: through study completion, 12 months after intervention implementation in all practices
|
% of patients using non-recommended preventive health services (e.g., prostate specific antigen screening)
|
through study completion, 12 months after intervention implementation in all practices
|
Collaborators and Investigators
Investigators
- Principal Investigator: Derjung M Tarn, MD,PhD, University of California, Los Angeles
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- R33AG068946 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The research team will engage the University of California Curation Center (UC3) to serve as the data repository for all components of the project. The research team will work with UC3 to curate and deliver to the curation center definition of data elements extracted from EHR and source data in a standardized, de-identified format. We also will include statistical codes for analyses in the form of R, SAS or STATA files.
The DRYAD system within the UC3 provides a platform to publish the metadata concerning the project that researchers globally can access. This system will serve as the data repository in which we will house the data management plan for the source data as well as metadata that describes the source data and code books of the underlying data elements, with record counts such that outside researchers can have a full understanding of what is housed in the system.
IPD Sharing Time Frame
IPD Sharing Access Criteria
Where possible data will be shared in an open file format, so proprietary software is not required to view or use the files. All datasets will be indexed by the Thomson-Reuters Data Citation Index, Scopus, and Google Dataset Search. Each dataset is given a unique Digital Object Identifier or DOI. Entering the DOI URL in any browser will take the user to the dataset's landing page. Dryad also provides a faceted search and browse capability for direct discovery.
Dryad has implemented the Make Data Count project recommendations. This means that that views and downloads on each dataset landing page are standardized against the COUNTER Code of Practice for Research Data. Within this framework, Dryad also exposes all related citations to a dataset on the landing page. These are updated each time a new citation from an article or other source has been published.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preventive Health Services
-
University of California, Los AngelesCase Western Reserve University; The MetroHealth System; American Academy of... and other collaboratorsNot yet recruitingPreventive Health Services
-
Seattle Children's HospitalUniversity of Washington; Kaiser PermanenteCompletedPreventive Health Services
-
University of WashingtonNational Institute of Dental and Craniofacial Research (NIDCR)UnknownPreventive Health ServicesUnited States
-
Seattle Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHealth Promotion | Preventive Health ServicesUnited States
-
University of California, Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHealth Promotion | Preventive Health ServicesUnited States
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingPresumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI)Preventive Health Services (PREV HEALTH SERV)United States
-
University of MalayaUniversity of Sheffield; The University of New South Wales; Leeds Beckett UniversityUnknownMass Screening | Preventive Health ServicesMalaysia
-
Pontificia Universidad Catolica de ChileFundacion MAPFRE; Fundacion Hispanoamericana de SolidaridadCompletedPreventive Medicine | Family | Family Practice | Adolescent Health Services | Primary Heath CareChile
-
Wroclaw Medical UniversityUnknownCardiovascular Diseases | Preventive Medicine | Fatty Acids | Anti-Inflammatory Agents | Eicosapentaenoic Acid | Preventive Health Services | Alpha-Linolenic Acid | Docosahexaenoic AcidsPoland
-
University of Colorado, DenverNational Cancer Institute (NCI); University of California, Los AngelesCompletedHPV Vaccine | Adolescent Health | Vaccine | Immunization | Reproductive Health | Preventive Health Services | Human Papiloma Virus Vaccine | Health RegistryUnited States
Clinical Trials on Medicare AWV Practice Redesign Toolkit
-
University of California, Los AngelesCase Western Reserve University; The MetroHealth System; American Academy of... and other collaboratorsNot yet recruitingPreventive Health Services
-
University of PittsburghUPMC Office of Community InitiativesCompleted
-
University of Alabama at BirminghamUS Department of Veterans Affairs; Agency for Healthcare Research and Quality...RecruitingUrinary IncontinenceUnited States
-
American Board of Internal MedicineThe Josiah Macy, Jr. FoundationCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPapillomavirus VaccinesUnited States